Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Injured in Crash on Interstate 205 Near Grant Line Road


Car Slams Into Wall in Tracy Accident 

Tracy, CA (March 30, 2020) – One person suffered serious injuries in a crash in Tracy. The accident occurred on the morning of March 30 on Interstate 205.

Two cars were swerving and driving recklessly on eastbound Interstate 205, near Grant Line Road. One car slammed into a wall on the right shoulder. One person suffered major injuries in the crash. They were taken to a local hospital. The other vehicle fled the accident scene. 

#Tracy

#95377


April 13, 2020

Boy Killed in Pedestrian Crash on Hazel Avenue

Teen Hit By Vehicle in Fatal Orangevale Accident ...


October 18, 2019

CHP Officer Injured in Crash at Lindley Avenue and Devonshire Street

Pursuit in Northridge Leads to Accident, Arrest Northridge, CA (October 17, 201...


May 1, 2020

1 Injured in Crash on Highway 108 Near Lover’s Leap

Vehicle Rolls Over in Oakdale Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.